Accenture (ACN) Proxy Filing summary
Event summary combining transcript, slides, and related documents.
Proxy Filing summary
12 Dec, 2025Voting matters and shareholder proposals
Election of ten nominees to the Board of Directors, with the board recommending a vote for each nominee.
Advisory vote to approve the compensation of named executive officers.
Approval of the Amended and Restated 2010 Share Incentive Plan.
Ratification of KPMG LLP as independent auditor and authorization for the Audit Committee to determine their remuneration.
Authorization for the Board to issue shares, opt out of pre-emption rights, and set the price range for re-allotment of treasury shares under Irish law.
Board of directors and corporate governance
Ten director nominees are presented for election at the annual meeting.
Board recommends voting in favor of all director nominees.
Executive compensation and say-on-pay
Advisory vote on executive compensation is included, with board support.
Proposal to approve the updated share incentive plan for executives and employees.
Latest events from Accenture
- Q3 FY26 revenue grew 6% to $18.7B, with EPS up 9% and strong shareholder returns.ACN
Q3 2026 - Record bookings, revenue growth, and raised outlook driven by AI and acquisitions.ACN
Q2 2026 - AI strategy is evolving rapidly, with ROI, specialization, and change management as top priorities.ACN
Fireside chat - Revenue up 6%, bookings up 12%, adjusted EPS up 10%, strong cash flow and returns.ACN
Q1 2026 - Board recommends all proposals amid strong performance, governance, and ESG focus.ACN
Proxy Filing - Q1 FY25 revenue up 9% to $17.7B; FY25 outlook raised, margin at 16.7%, $1.8B returned.ACN
Q1 2025 - Record bookings, margin expansion, and robust FY25 outlook highlight strong momentum.ACN
Q4 2024 - Q3 bookings hit $21.1B, GenAI surged, and FY24 guidance signals steady growth.ACN
Q3 2024 - Q2 FY25 revenue up 8.5% local currency, strong bookings, and raised FY25 outlook despite uncertainty.ACN
Q2 2025